The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients
Pharma giant targets new standards of care
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
It is actually a new ISO Class 5 controlled cleanroom designed to deliver washed, dried, and gamma-sterilized single-use assemblies ready for immediate use.
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Targets high-growth eye care expansion push
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
